Page last updated: 2024-10-29

ifosfamide and Myasthenia Gravis

ifosfamide has been researched along with Myasthenia Gravis in 1 studies

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research Excerpts

ExcerptRelevanceReference
"Thymomas and thymic carcinomas are unique tumors of the anterior mediastinum."2.41Thymic malignancies. ( Loehrer, PJ; Wick, MR, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loehrer, PJ1
Wick, MR1

Reviews

1 review available for ifosfamide and Myasthenia Gravis

ArticleYear
Thymic malignancies.
    Cancer treatment and research, 2001, Volume: 105

    Topics: Adrenal Cortex Hormones; Agammaglobulinemia; Antineoplastic Agents; Antineoplastic Combined Chemothe

2001